FDA Approved: YUTIQ — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved YUTIQ (fluocinolone acetonide) through ANI Pharmaceuticals' original application for the treatment of noninfectious posterior segment uveitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Noninfectious Posterior Segment Uveitis

Drugs mentioned

• YUTIQ (fluocinolone acetonide)

Snippet

ORIG AP for YUTIQ (FLUOCINOLONE ACETONIDE)